| Ident. | Authors (with country if any) | Title |
|---|
| 000093 (2021) |
Derek Shyr [États-Unis] ; Yu Shyr [États-Unis] | The design and analysis of non-randomized studies: a case study of off-label use of hydroxychloroquine in the COVID-19 pandemic. |
| 000125 (2021) |
Andy Sing Ong Tang ; Tze Shin Leong ; Lee Ping Chew ; Hock Hin Chua | Successful Non-surgical Treatment of an Acute Calculous Cholecystitis in a Myeloma Patient with Covid-19: Case Report. |
| 000195 (2021) |
Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Jean-Christophe Lagier [France] ; Didier Raoult [France] | Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial. |
| 000218 (2021) |
Marcelo Rodrigues Dos Santos [Brésil] | Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial. |
| 000302 (2021) |
Roberta Gagliardini [Italie] ; Alessandro Cozzi-Lepri [Royaume-Uni] ; Andrea Mariano [Italie] ; Fabrizio Taglietti [Italie] ; Alessandra Vergori [Italie] ; Amina Abdeddaim [Italie] ; Francesco Di Gennaro [Italie] ; Valentina Mazzotta [Italie] ; Alessandra Amendola [Italie] ; Giampiero D'Offizi [Italie] ; Fabrizio Palmieri [Italie] ; Luisa Marchioni [Italie] ; Pierluca Piselli [Italie] ; Chiara Agrati [Italie] ; Emanuele Nicastri [Italie] ; Maria Rosaria Capobianchi [Italie] ; Nicola Petrosillo [Italie] ; Giuseppe Ippolito [Italie] ; Francesco Vaia [Italie] ; Enrico Girardi [Italie] ; Andrea Antinori [Italie] | No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison. |
| 000324 (2021) |
S. Verheijen [Pays-Bas] ; M. Van Luin [Pays-Bas] ; R J Brüggemann [Pays-Bas] ; Q. De Mast [Pays-Bas] ; R J Hassing [Pays-Bas] ; D M Burger [Pays-Bas] | More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine. |
| 000331 (2021) |
Haruna Isiyaku Umar [Nigeria, Inde] ; Bushra Siraj [Inde, Pakistan] ; Adeola Ajayi [Nigeria] ; Tajudeen O. Jimoh [Thaïlande, Ouganda] ; Prosper Obed Chukwuemeka [Nigeria] | Molecular docking studies of some selected gallic acid derivatives against five non-structural proteins of novel coronavirus. |
| 000356 (2021) |
Mohamed O. Saad [Qatar] | Letter to the editor about "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial". |
| 000417 (2021) |
Alasdair Macgowan [Royaume-Uni] ; Fergus Hamilton [Royaume-Uni] ; Mark Bayliss [Royaume-Uni] ; Liam Read [Royaume-Uni] ; Marie Attwood [Royaume-Uni] ; Alan Noel [Royaume-Uni] ; Sally Grier [Royaume-Uni] ; Anna Morley [Royaume-Uni] ; David Arnold [Royaume-Uni] ; Nicholas Maskell [Royaume-Uni] | Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS-CoV-2. |
| 000447 (2021) |
Risa Ebina-Shibuya [États-Unis] ; Ho Namkoong [États-Unis] ; Nobuyuki Horita [Japon] ; Hideaki Kato [Japon] ; Yu Hara [Japon] ; Nobuaki Kobayashi [Japon] ; Takeshi Kaneko [Japon] | Hydroxychloroquine and chloroquine for treatment of coronavirus disease 19 (COVID-19): a systematic review and meta-analysis of randomized and non-randomized controlled trials. |
| 000448 (2021) |
Philippe Gautret [France] ; Jean-Christophe Lagier [France] ; Stéphane Honoré [France] ; Van Thuan Hoang [Viêt Nam] ; Philippe Colson [France] ; Didier Raoult [France] | Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited. |
| 000451 (2021) |
Narimana Imanova Yaghji [Turquie] ; Elif Kilic Kan [Turquie] ; Songul Akcan [Turquie] ; Ramis Colak [Turquie] ; Aysegul Atmaca [Turquie] | Hydroxychloroquine Sulfate Related Hypoglycemia In A Non-Diabetic COVİD-19 Patient: A Case Report and Literature Review. |
| 000479 (2021) |
Carlos Gustavo Wambier [États-Unis] | Focus on clinical outcomes of "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial". |
| 000498 (2021) |
Rupesh Agrawal [Singapour, Royaume-Uni] ; Ilaria Testi [Royaume-Uni] ; Cecilia S. Lee [États-Unis] ; Edmund Tsui [États-Unis] ; Marian Blazes [États-Unis] ; Jennifer E. Thorne [États-Unis] ; Annabelle A. Okada [Japon] ; Justine R. Smith [Australie] ; Peter J. Mccluskey [Australie] ; John H. Kempen [États-Unis, Éthiopie] ; Christoph Tappeiner [Suisse] ; Manisha Agarwal [Inde] ; Bahram Bodaghi [France] ; Quan Dong Nguyen [États-Unis] ; Vishali Gupta [Inde] ; Marc D. De Smet [Belgique] ; Manfred Zierhut [Allemagne] ; Carlos Pavesio [Royaume-Uni] | Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic. |
| 000524 (2021) |
Amirreza Roostaei Firozabad [Iran] ; Zohreh Akhoundi Meybodi [Iran] ; Seyed Ruhollah Mousavinasab [Iran] ; Adeleh Sahebnasagh [Iran] ; Mohsen Gholinataj Jelodar [Iran] ; Iman Karimzadeh [Iran] ; Solomon Habtemariam [Royaume-Uni] ; Fatemeh Saghafi [Iran] | Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial. |
| 000529 (2021) |
Tanya Tandon [Inde] ; Ashok Kumar Dubey [Inde] ; Suparna Dubey [Inde] ; Ekta Arora [Inde] ; Md Nazer Hasan [Inde] | Effects of COVID-19 pandemic lockdown on medical advice seeking and medication practices of home-bound non-COVID patients. |
| 000542 (2021) |
Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Jean-Christophe Lagier [France] ; Didier Raoult [France] | Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes. |
| 000546 (2021) |
Luis Gabriel Parra-Lara [Colombie] ; Juan José Martinez-Arboleda [Colombie] ; Daniel Francisco Isaza-Pierotti [États-Unis] ; Fernando Rosso [Colombie] | Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial. |
| 000626 (2021) |
David M. Nemer [États-Unis] ; Bryan R. Wilner [États-Unis] ; Alicia Burkle [États-Unis] ; Jose Aguilera [États-Unis] ; Joseph Adewumi [États-Unis] ; Carl Gillombardo [États-Unis] ; Oussama Wazni [États-Unis] ; Venu Menon [États-Unis] ; Shannon Pengel [États-Unis] ; Meredith Foxx [États-Unis] ; Marc Petre [États-Unis] ; Aaron C. Hamilton [États-Unis] ; Daniel J. Cantillon [États-Unis] | Clinical Characteristics and Outcomes of Non-ICU Hospitalization for COVID-19 in a Nonepicenter, Centrally Monitored Healthcare System. |
| 000809 (2020) |
Nijad Bakhshaliyev [Turquie] ; Mahmut Uluganyan [Turquie] ; Asim Enhos [Turquie] ; Erdem Karacop [Turquie] ; Ramazan Ozdemir [Turquie] | The effect of 5-day course of hydroxychloroquine and azithromycin combination on QT interval in non-ICU COVID19(+) patients. |
| 000903 (2020) |
Mohammed M. Alvi [États-Unis] ; Sowmya Sivasankaran [États-Unis] ; Mahima Singh [États-Unis] | Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-19. |
